Movilo® expands its range of applications

The proven Movilo® Comfort Shoe from DARCO now offers an expanded range of applications in patient care. With the addition of two new indications, it now covers additional risk groups in accordance with the criteria of the German Diabetes Society (DDG).

New additional indications at a glance:

• Diabetes mellitus without PNP / PAOD with foot deformity (risk group 1 according to the German Diabetes Society)
• Diabetes mellitus with sensory loss due to PNP / relevant PAD (risk group 2a according to the German Diabetes Society)

Movilo® now also supports patients with sensitive feet, foot deformities, or circulation problems.

The proven combination of medical-therapeutic expertise and high wearing comfort ensures safe, comfortable walking in everyday life and during leisure time.

More about Movilo® Comfort Shoes from DARCO